Showing results (581-590 of 977) with videos related to
Sort By:
Pageof 98
Journal of Medicinal Chemistry|February 7, 2001
N-3-substituted imidazoquinazolinones: potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunctionD P Rotella, Z Sun, Y Zhu, et al.Tissue Antigens|February 13, 2001
Downregulation of the constitutive tapasin expression in human tumor cells of distinct origin and its transcriptional upregulation by cytokinesB Seliger, K Schreiber, K Delp, et al.Journal of Medicinal Chemistry|January 11, 2001
Optimization of substituted N-3-benzylimidazoquinazolinone sulfonamides as potent and selective PDE5 inhibitorsD P Rotella, Z Sun, Y Zhu, et al.Cancer Immunology, Immunotherapy : CII|October 13, 2009
Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancerBarbara Seliger, Robert Stoehr, Diana Handke, et al.International Journal of Environmental Research and Public Health|March 11, 2023
Suicide Mortality Risk among Patients with Lung Cancer-A Systematic Review and Meta-AnalysisLuisa Hofmann, Michael Heinrich, Hansjörg Baurecht, et al.Oncotarget|October 22, 2015
VHL-dependent alterations in the secretome of renal cell carcinoma: Association with immune cell response?Franziska Stehle, Sandra Leisz, Kristin Schulz, et al.Oncoimmunology|March 5, 2016
Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosisEmilia Andersson, Isabel Poschke, Lisa Villabona, et al.European Journal of Medicinal Chemistry|December 3, 2014
Screening of synthetic and natural product databases: Identification of novel androgens and antiandrogensClaudia Bobach, Stephanie Tennstedt, Kristin Palberg, et al.International Journal of Molecular Sciences|February 21, 2020
In Vivo and In Vitro Mechanical Loading of Mouse Achilles Tendons and Tenocytes-A Pilot StudyViviane Fleischhacker, Franka Klatte-Schulz, Susann Minkwitz, et al.Cancer Immunology, Immunotherapy : CII|January 20, 2012
Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancerEmilia Andersson, Lisa Villabona, Kjell Bergfeldt, et al.Pageof 98